4.6 Review

Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1

Journal

TRENDS IN BIOCHEMICAL SCIENCES
Volume 35, Issue 1, Pages 36-42

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2009.07.009

Keywords

-

Funding

  1. Biotechnology and Biological Sciences Research Council (BBSRC)
  2. Jasper L. and Jack Denton Wilson Foundation
  3. US Army [W81XWH05-1-0316]
  4. NIH [GM61905]
  5. Skaggs Chemical Biology Foundation
  6. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061905] Funding Source: NIH RePORTER
  7. Biotechnology and Biological Sciences Research Council [BB/F008333/1] Funding Source: researchfish
  8. Medical Research Council [G0401165] Funding Source: researchfish
  9. BBSRC [BB/F008333/1] Funding Source: UKRI
  10. MRC [G0401165] Funding Source: UKRI

Ask authors/readers for more resources

Multidrug ABC transporters can transport a wide range of drugs from the cell. Ongoing studies of the prototype mammalian multidrug resistance ATP-binding cassette transporter P-glycoprotein (ABCB1) have revealed many intriguing functional and biochemical features. However, a gap remains in our knowledge regarding the molecular basis of its broad specificity for structurally unrelated ligands. Recently, the first crystal structures of ligand-free and ligand-bound ABCB1 showed ligand binding in a cavity between its two membrane domains, and earlier observations on polyspecificity can now be interpreted in a structural context. Comparison of the new ABCB1 crystal structures with structures of bacterial homologs suggests a critical role for an axial rotation of transmembrane helices for high-affinity binding and low-affinity release of ligands during transmembrane transport.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available